Santé Ventures

  • Approach
  • Team
  • Portfolio
  • Media Room
  • Contact

Santé Ventures » Team

Investment Team

  • Web-Kevin_Lalande-8844-Edit- (Zoom) Kevin M. Lalande
    Managing Director
  • Web-Joe_Cunningham-8232-Edit- (Zoom) Joe Cunningham, MD
    Managing Director
  • Web-Doug_French-8090-Edit- (Zoom) Douglas D. French
    Managing Director
  • Web-James_Eadie-8373-Edit- (Zoom) James Eadie, MD
    Partner
  • Web-Casey_Cunningham-8172-Edit- (Zoom) Casey Cunningham, MD
    Chief Scientific Officer
  • Web-Dave_Kaufman-6765-Edit-- (Zoom) David Kaufman
    Chief Operating Officer
  • Web-Louis_Bock-8285-Edit- (Zoom) Louis Bock
    Venture Partner
  • william cohn_original-2 (Zoom) Billy Cohn, MD
    Venture Partner
  • Web-Dennis_McWilliams-5964-Edit (Zoom) Dennis McWilliams
    Venture Partner
  • Web-Michael_Hoffman-6982-Edit- (Zoom) Michael Hoffman
    Senior Advisor
  • Web-Jason_Brandt-8469-Edit- (Zoom) Jason Brandt, CPA
    Chief Financial Officer and Chief Compliance Officer
  • Web-Diane_Brouillard-8298-Edit-(Zoom) Diane Brouillard
    Head of Talent & Networks
  • Web-Brett_Skukauski-6853-Edit- (Zoom) Brett Skukauski
    Controller
  • Web-Derek_Mazur-8517-Edit- (Zoom) Derek Mazur
    Senior Associate
  • Web-Eric_Epstein-2353-Edit-whitebkg (Zoom) Eric Epstein
    Senior Associate
  • Web-Derek_Dedeker-8323-Edit- (Zoom) Derek Dedeker
    Senior Analyst
  • Web-Jake_Rogers-8644-Edit- (Zoom) Jake Rogers
    Operations Associate
  • Julia_1570 Julia Rhee
    Director of Marketing and Investor Relations
News
November 21, 2019 Molecular Templates, Inc. Announces Pricing of $50.0 Million Public Equity Offering
Read More
November 18, 2019 Vertex and Molecular Templates Establish Collaboration to Discover and Develop Novel Targeted Conditioning Regimens to Enhance Hematopoietic Stem Cell Transplants
Read More
  • Team
  • Advisors

© Copyright 2019. All Rights Reserved.

Home | Approach | Team | Portfolio | Media Room | Contact

NVCA 2011-2012 Member